Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,635 USD | +0,11% | -12,12% | +9,12% |
22/04 | Hooggerechtshof verwerpt zaak Vanda Pharmaceuticals over octrooien op slaapmiddelen | RE |
19/04 | Butler Hall Capital dringt bij Vanda aan op verkoopgesprekken | RE |
Omzet 2022 | 254 mln. 238 mln. | Omzet 2023 | 193 mln. 180 mln. | Marktkapitalisatie | 243 mln. 227 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 6 mln. 5,61 mln. | Nettowinst (verlies) 2023 | 2 mln. 1,87 mln. | EV/omzet 2022 | -0,15 x |
Nettoliquiditeiten 2022 | 456 mln. 426 mln. | Nettoliquiditeiten 2023 | 379 mln. 354 mln. | EV/omzet 2023 | -0,71 x |
K/w-verhouding 2022 |
67,2
x | K/w-verhouding 2023 |
106
x | Werknemers | 203 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 94,79% |
Recentste transcriptie over Vanda Pharmaceuticals Inc.
1 dag | -3,54% | ||
1 week | +14,32% | ||
Lopende maand | +12,65% | ||
1 maand | +19,02% | ||
3 maanden | +24,80% | ||
6 maanden | +9,20% | ||
Lopend jaar | +9,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 64 | 01-11-02 | |
Kevin Moran
DFI | Director of Finance/CFO | 40 | 01-12-12 |
Scott Howell
HRO | Human Resources Officer | - | 01-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard W. Dugan
BRD | Director/Board Member | 82 | 01-12-05 |
Chief Executive Officer | 64 | 01-11-02 | |
Director/Board Member | 72 | 14-02-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.34% | 29 M€ | -3,61% | ||
0.22% | 27 M€ | -4,16% | - | |
0.05% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 4,605 | -0,54% | 682 107 |
23-04-24 | 4,63 | -3,54% | 1 371 417 |
22-04-24 | 4,8 | -6,07% | 2 114 924 |
19-04-24 | 5,11 | +2,82% | 2 440 757 |
18-04-24 | 4,97 | -5,15% | 3 859 528 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+9,72% | 266 mln. | |
-0,49% | 105 mld. | |
+3,31% | 97,5 mld. | |
+1,66% | 22,19 mld. | |
-16,16% | 21,33 mld. | |
-6,82% | 18,68 mld. | |
-41,41% | 16,6 mld. | |
-22,87% | 14,52 mld. | |
+6,32% | 14,09 mld. | |
+21,46% | 10,99 mld. |